Last reviewed: June 9, 2026
Last updated: June 9, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Ozempic, reduces appetite by activating GLP-1 receptors in the brain and slowing stomach emptying—a mechanism that produces weight loss in clinical trials. While Ozempic carries the diabetes indication, many physicians prescribe it off-label for weight management. PlexusDx offers access to compounded semaglutide injections through licensed 503A pharmacies, providing a transparent alternative to brand-name options.
How Ozempic and Semaglutide Work for Weight Loss
Semaglutide mimics glucagon-like peptide-1 (GLP-1), a natural hormone that tells your brain you are full and satisfied. When you inject semaglutide weekly, it binds to GLP-1 receptors throughout your nervous system and gut, signaling satiety before you finish a typical meal. This dual action—reduced hunger and slower digestion—creates the calorie deficit needed for steady weight reduction without severe dietary restriction.
Clinical trials showed participants lost an average of 15% of their body weight over 68 weeks using semaglutide 2.4 mg weekly, compared to 2.4% in the placebo group. The weight loss effect emerges gradually; most people see noticeable changes after 4 to 8 weeks of consistent dosing. Semaglutide's impact on appetite control is so pronounced that many patients report eating significantly smaller portions without feeling deprived.
Who Is a Good Candidate for Semaglutide Weight Loss Therapy
You may be a candidate for semaglutide weight loss if you have a body mass index (BMI) of 30 or higher, or a BMI of 27 with weight-related health conditions like high blood pressure or sleep apnea. Semaglutide works best for people who struggle with appetite control and portion size rather than those who eat normally but move minimally. Your medical history matters—those with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 should avoid GLP-1 medications entirely.
PlexusDx offers the Precision Peptide Genetic Test, which analyzes how your unique genetic variants in the GLP1R, GIPR, FTO, and MC4R genes influence your response to peptide-based therapies. This personalized insight helps you and your clinician predict whether semaglutide is likely to produce meaningful weight loss for your body, reducing guesswork and optimizing your treatment plan from day one.
Potential Side Effects and Risks of Semaglutide
The most common side effects of semaglutide are gastrointestinal: nausea, vomiting, diarrhea, and constipation, especially when first starting or increasing your dose. These symptoms typically fade within 2 to 4 weeks as your body adapts; taking your injection on an empty stomach or eating small, low-fat meals can reduce nausea. Serious but rare risks include pancreatitis (sudden severe abdominal pain), gallbladder issues, and retinal complications in people with existing diabetic eye disease.
Dehydration is an underrecognized risk because reduced appetite can lead some people to drink less fluid while their bodies are processing more efficiently. Some patients experience muscle loss alongside fat loss, particularly if they do not maintain adequate protein intake and strength training. If you develop rapid heartbeat, severe stomach pain, or signs of allergic reaction (swelling, rash), contact your healthcare provider immediately.
Ozempic vs. PlexusDx Compounded Semaglutide: Key Differences
Ozempic is a brand-name, FDA-approved semaglutide injection manufactured by Novo Nordisk and marketed for type 2 diabetes; off-label weight loss prescriptions are common but not the drug's primary indication. Ozempic typically costs $900–$1,200 per month through insurance or cash pay, and many insurance plans deny coverage for weight loss use. PlexusDx compounded semaglutide injections contain the same active pharmaceutical ingredient but are prepared by licensed 503A compounding pharmacies and start at $149 per month, with no insurance required and HSA/FSA eligibility.
Compounded medications allow for flexible dosing tailored to your response and tolerance, whereas Ozempic comes in fixed pens (0.25 mg, 0.5 mg, 1 mg, 2 mg). PlexusDx serves all 50 states with no membership fees, no insurance gatekeeping, and direct access to telehealth clinicians who oversee your therapy. Both products deliver semaglutide—the difference lies in cost transparency, accessibility, and personalized dosing flexibility.
How to Start Semaglutide Safely and What to Expect
Starting semaglutide requires a medical consultation with a licensed clinician who will review your health history, medications, and weight loss goals. The typical starting dose is 0.25 mg injected subcutaneously once per week, with incremental increases every 4 weeks (0.5 mg, 1 mg, 1.5 mg, 2 mg, and up to 2.4 mg) based on your tolerance and response. Your clinician may adjust your pace if side effects are bothersome or if you are achieving your target without escalating further.
Most people experience appetite suppression within days of their first injection, though meaningful weight loss on the scale takes 2 to 4 weeks to appear. Expect to lose 1 to 2 pounds per week initially, with the rate slowing after 12 to 16 weeks; this plateau is normal and reflects your body reaching a new, sustainable weight. Keep a symptom log and stay hydrated; report any severe nausea, abdominal pain, or chest discomfort to your healthcare provider immediately.
Maintaining Results After Semaglutide: Long-Term Strategy
Weight loss is maintained while you remain on semaglutide; stopping the medication typically allows appetite to return and weight to regain over months. Most people benefit from staying on therapy long-term (1 to 2 years or more) as a chronic weight management tool, similar to blood pressure medication. PlexusDx supports sustained therapy with flexible pricing across three commitment tiers—your dose may need to go up, but your price won't.
Combining semaglutide with lifestyle changes—strength training, adequate protein intake, and consistent sleep—produces superior outcomes and may allow you to maintain weight loss if you eventually taper off. Some clinicians recommend cycling to assess whether you can maintain weight reduction without medication after 18 to 24 months; this decision is personal and should be made with your provider. Regaining weight after stopping does not mean you failed; it reflects the powerful biological drive to return to your baseline, and restarting semaglutide at any point remains an option.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Ozempic approved by the FDA for weight loss?
No, Ozempic is FDA-approved only for type 2 diabetes management. Doctors prescribe it off-label for weight loss, which is legal but not the official indication. PlexusDx compounded semaglutide is prepared by licensed 503A pharmacies and offers the same active ingredient at a fraction of the brand-name cost.
How much weight can I realistically lose on semaglutide?
Clinical trials show an average loss of 15% of body weight over 68 weeks (roughly 30–50 pounds for a 200-pound person), though individual results vary based on genetics, diet, exercise, and adherence. The Precision Peptide Genetic Test helps predict your likely response by analyzing your GLP1R and GIPR variants.
How much does PlexusDx compounded semaglutide cost per month?
PlexusDx compounded semaglutide injections start at $149 per month, with no flat per-compound pricing increases—your dose may need to go up, your price won't. The medication is HSA/FSA eligible and available nationwide without insurance or membership fees.
What are the most serious risks of semaglutide therapy?
Rare serious risks include pancreatitis, gallbladder disease, and worsening of diabetic retinopathy in people with existing eye disease. Avoid semaglutide entirely if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2. Discuss all pre-existing conditions with your clinician before starting.
How does the PlexusDx Precision Peptide Genetic Test help me?
The test analyzes 14 metabolic pathways and 49 peptides, including your GLP1R, GIPR, FTO, and MC4R variants, to predict how strongly you will respond to GLP-1 therapies like semaglutide. This $99 add-on (after your first month of treatment) removes guesswork and helps your clinician optimize your therapy plan for maximum results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding Mounjaro: The Tirzepatide Injection and Its Role in Weight Management
How to Wean Off Semaglutide for Weight Loss: A Comprehensive Guide